AVEIR leadless pacemaker registry for heart patients in Europe and Middle East
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is collecting data on people who get a small, leadless pacemaker (AVEIR) for slow or irregular heartbeats. It helps doctors learn how well this type of pacemaker works in everyday patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need a pacemaker because your heart beats too slowly or irregularly, according to heart guidelines.
- You must be 18 or older (or the legal age in your country).
- You need to be able to come back to the clinic for follow-up visits after the pacemaker is placed.
- You must understand the study and sign a consent form.
- You cannot have another medical device that could interfere with the pacemaker's wireless connection.
- You should not have a life expectancy of less than one year or be pregnant/nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is an observational registry for people who have or will receive an AVEIR leadless pacemaker. It collects information to help doctors understand how the device performs over time.
This trial tests a new pacemaker system for people who need a pacemaker for a slow or irregular heartbeat. It aims to see if the system is safe and works well.
This study tracks the safety and performance of AVEIR VR LP and AVEIR AR LP leadless pacemakers in people who already have them or will get one. It helps doctors and researchers see how well these small heart devices work over time.
This study looks at how well a new type of pacemaker, called Aveir AR, works for people with Medicare. It helps doctors understand if this leadless pacemaker is safe and effective for treating slow heart rhythms.
This trial is for people who already have an Aveir leadless pacemaker and either were in a previous study or need to upgrade from a single-chamber to a dual-chamber system. It helps monitor the device's performance in real-world use.
This study uses your medical records from Medicare to learn how the Aveir DR leadless pacemaker performs in everyday life after it’s implanted. It mainly helps researchers and doctors understand real-world outcomes and care needs.
Hear when a new Cardiac Pacing in Adherence With ESC Cardiac Pacing Guidelines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.